Posted in | News | Gold

Dia Bras Exploration Reports Stream Sediment Sampling Results from La Verde Prospect

Dia Bras Exploration has released the further assay results of the stream sediment sampling campaign, which is performed at the La Verde gold prospect located at the Batopilas property in Mexico.

These additional results have made the company to focus on certain gold-anomalous edges, which will be intercepted after the completion of the rainy season during 2011 the fourth quarter.

The location of the Batopilas property’s La Verde prospect is 35 km to the southeast part of the Bolivar property and 23 km to the El Sauzal gold mine’s eastern portion. The alteration associated with a high-sulfidation gold system is present over a region of above 25 sq. km in the La Verde region and it is in this broad alteration region. A northwest trend occurs to the quartz veinlets, veins and stockworks, housing the previous Tres Hermanos mine. The Dia Bras property did not host this mine, but hosts the trend’s expansion.

The company is drilling the Batopilas property, which encloses 45,319 and contains the Satevo epithermal gold mineralization and the copper-molybdenum deposit hosting Corralitos intrusion.

These recent stream sediment sample results have shown up to 660 ppb of gold sediments and additionally 969 ppm copper, 207 ppm lead and 346 ppm zinc.

Two stream-sediment sampling has been performed to outline extensive gold anomalies in La Verde prospect. Gathering of a further 88 sediment samples from the La Verde region are contained in this latest campaign.

During late 2011, the company will carry on stream sampling at the La Verde region and will commence a comprehensive rock chip sampling and geologic mapping of the gold anomalous edges with the objective of drilling the region initially during 2012.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dia Bras Exploration Inc.. (2019, February 18). Dia Bras Exploration Reports Stream Sediment Sampling Results from La Verde Prospect. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=5234.

  • MLA

    Dia Bras Exploration Inc.. "Dia Bras Exploration Reports Stream Sediment Sampling Results from La Verde Prospect". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=5234>.

  • Chicago

    Dia Bras Exploration Inc.. "Dia Bras Exploration Reports Stream Sediment Sampling Results from La Verde Prospect". AZoMining. https://www.azomining.com/News.aspx?newsID=5234. (accessed November 21, 2024).

  • Harvard

    Dia Bras Exploration Inc.. 2019. Dia Bras Exploration Reports Stream Sediment Sampling Results from La Verde Prospect. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=5234.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.